
王增斌
硕士研究生导师,免疫学系学系副主任
联系邮箱:[email protected]
个人简介
王增斌,男,讲师,硕士生研究生导师。临床检验诊断学专业博士。福建省高层次人才,熟女a片 “青年之星”,熟女a片 “宗濂计划”人才。福建省免疫系学会青年委员会常务委员。以第一/通讯作者发表SCI论文15篇(一作13篇,通讯2篇);总影响因子>100。研究成果被Science Signaling期刊选为封面论文重点推荐,被Nat Rev Immunol,Nat Rev Mol Cell Biol及Semin Immunol等顶级期刊引用和正面评价。担任J Cell Commun Signal(JCR2区)杂志的Associate Editor和多个SCI期刊审稿人。指导本科生发表SCI论文2篇,获得生命科学竞赛(创新创业类)国赛三等奖1项。
研究领域
1.蛋白修饰与肿瘤免疫
2. 肝损伤与免疫代谢
主持/参与的项目
1. 国家自然科学基金青年项目,SPTAN1乳酸化抑制DNA甲基化促进HBV相关肝细胞癌进展的机制研究,2025-01至2027-12,30万元, 主持;
2. 福建省自然科学基金青创项目,可变剪接因子Rbm17调控肝癌细胞牛磺胆酸代谢促进免疫抑制的机制研究,2024-11至2027-11,8万元,主持;
3. 福建省科技创新联合资金项目,瘤内菌激活Ripk2以巨噬细胞依赖性的方式影响CD8+T细胞抗肿瘤免疫应答的机制研究,2024-11至 2027-12,15万元, 主持;
4. 熟女a片 高层次人才科研启动项目, 主持,探究肿瘤微环境中增殖型巨噬细胞“Prolif Ms”的功能特点,2023-09至2026-09, 15万元,主持;
5. 福建省中青年教师教育科研(科技类)重点项目,内质网应激介导NOD1/2/RIPK2参与多柔比星诱导肝损伤的机制研究,2024-01至 2027-01, 10万元, 主持;
6. 福建省卫生健康重大科研专项,新型肝癌介入综合治疗体系构建,2025-01至 2028-12, 300万元, 参与;
科研成果
1. Wang Z, Ye D, Wu L, Liu J, Pan B, Zhang Z, Zhang X, Yao Y, Tang N. Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression. Advanced Science. 2025;16:e07068. (一作一,IF=14.1,中科院1区top);
2. Pan B, Yu H, Lin Z, Liu M, Liu J, Xu Y, Wu L, Zhang Q, Wang Z. RNASEH2C enhances TRAF3IP1 to degrade RAI14 in lysosomes thus hindering macrophage antigen presentation and advancing liver cancer. Cell Death Dis. 2025 Dec 8;17(1):92. (末位通讯,IF=9.6,中科院1区top);
3. Wang Z, Liu J, Lai Y, Zhong Q, Su Q, Wu L, Wang Z, Fang Z. RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting. Cell Death Discov. 2025 Jul 23;11(1):338.(一作一,IF=7.0,中科院2区top);
4. Wang Z, Pan B, Qiu J, Zhang X, Ke X, Shen S, Wu X, Yao Y, Tang N. SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape. Sci Signal. 2023 Mar 14;16(776):eabq3362. (一作一,IF: 9.7,中科院1区top);
5. Wang Z, Sun P, Pan B, Qiu J, Zhang X, Shen S, Ke X, Tang N. IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunity. Cell Commun Signal. 2023 Apr 20;21(1):80. (一作一,IF: 7.5,中科院2区);
6. Wang Z, Pan B, Su L, Yu H, Wu X, Yao Y, Zhang X, Qiu J, Tang N. SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma. Cell Oncol (Dordr). 2024 Apr;47(2):513-532. (一作一,IF: 6.6,中科院2区);
7. Wang Z, Wu L, Pan B, Chen Y, Zhang T, Tang N. Interleukin 33 mediates hepatocyte autophagy and innate immune response in the early phase of acetaminophen-induced acute liver injury. Toxicology. 2021 May 30;456:152788. (一作一,IF: 4.6,中科院2区);
8. Wang Z, Tang N. Unpacking the complexity of nuclear IL-33 (nIL-33): a crucial regulator of transcription and signal transduction. J Cell Commun Signal. 2023 Dec;17(4):1131-1143. (一作一,IF: 3.9,中科院3区);
9. Wang Z, Wu L, Zhou Y, Chen Z, Zhang T, Wei H, Wang Z. Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells. Front Pharmacol. 2024 May 21;15:1394241. (一作一,IF: 4.8,中科院2区);
10. Tang B, Ouyang H, Zheng S, Yu L, Xiao R, Wu L, Wang Z. Doxorubicin promotes NK cell dysfunction and induces acute liver injury through kynurenine-AhR axis. Int Immunopharmacol. 2025 Apr 24;153:114489. (末位通讯,IF: 4.7,中科院2区)。
(更新于2026年3月)
![]() |

